Coya Therapeutics holders elect directors, ratify auditor
Coya Therapeutics, Inc. reported the results of its Annual Meeting of Stockholders held on June 25, 2026.
Rhea-AI Filing Summary
Coya Therapeutics, Inc. reported the results of its Annual Meeting of Stockholders held on June 25, 2026. Stockholders elected two Class I directors to new three-year terms and ratified the company’s independent auditor for the 2026 fiscal year.
Secretary Wilbur Ross received 9,168,496 votes for and 2,818,233 withheld, with 4,585,732 broker non-votes. Dieter Weinand received 10,566,702 votes for and 1,420,027 withheld, with the same 4,585,732 broker non-votes. Stockholders also ratified Weaver and Tidwell, L.L.P. as the independent registered public accounting firm with 16,545,887 votes for, 22,661 against, and 3,913 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Votes for Wilbur Ross: 9,168,496 votes
Votes withheld Wilbur Ross: 2,818,233 votes
Votes for Dieter Weinand: 10,566,702 votes
+5 more
8 metrics
Votes for Wilbur Ross
9,168,496 votes
Election as Class I director at June 25, 2026 annual meeting
Votes withheld Wilbur Ross
2,818,233 votes
Election as Class I director at June 25, 2026 annual meeting
Votes for Dieter Weinand
10,566,702 votes
Election as Class I director at June 25, 2026 annual meeting
Votes withheld Dieter Weinand
1,420,027 votes
Election as Class I director at June 25, 2026 annual meeting
Broker non-votes on director election
4,585,732 votes
Director election proposals at annual meeting
Votes for auditor ratification
16,545,887 votes
Ratification of Weaver and Tidwell, L.L.P. for 2026
Votes against auditor ratification
22,661 votes
Ratification of Weaver and Tidwell, L.L.P. for 2026
Abstentions on auditor ratification
3,913 votes
Ratification of Weaver and Tidwell, L.L.P. for 2026
Key Terms
broker non-votes, independent registered public accounting firm, Emerging growth company, Annual Meeting of Stockholders
4 terms
broker non-votes financial
"The votes were cast for this matter were as follows ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Emerging growth company regulatory
"Emerging growth company On June 25, 2026, Coya Therapeutics, Inc."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Annual Meeting of Stockholders financial
"held its Annual Meeting of Stockholders (the “Annual Meeting”)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Coya Therapeutics (COYA) stockholders approve at the June 25, 2026 meeting?
Stockholders elected two Class I directors and ratified the external auditor. Secretary Wilbur Ross and Dieter Weinand were elected to three-year terms, and Weaver and Tidwell, L.L.P. was confirmed as independent registered public accounting firm for the fiscal year ending December 31, 2026.
How many votes did Coya Therapeutics director nominee Wilbur Ross receive?
Secretary Wilbur Ross received 9,168,496 votes for election and 2,818,233 votes withheld. There were also 4,585,732 broker non-votes recorded for this proposal, which represent shares present but not voted on the director item by certain intermediaries.
How many votes did Coya Therapeutics director nominee Dieter Weinand receive?
Dieter Weinand received 10,566,702 votes for election and 1,420,027 votes withheld. As with the other director nominee, there were 4,585,732 broker non-votes, meaning some beneficially owned shares were not instructed on the director proposal by their brokers.
What were the auditor ratification voting results for Coya Therapeutics (COYA)?
Stockholders strongly supported ratifying Weaver and Tidwell, L.L.P. as auditor, with 16,545,887 votes for, 22,661 against, and 3,913 abstentions. This confirms the firm as Coya Therapeutics’ independent registered public accounting company for the fiscal year ending December 31, 2026.
What is the term length for the Class I directors elected at Coya Therapeutics’ 2026 meeting?
The Class I directors, Secretary Wilbur Ross and Dieter Weinand, will each serve a three-year term. They hold office until their successors are duly elected and qualified or until they are otherwise unable to complete their respective terms as directors.
AI-generated analysis. How Rhea-AI works. Not financial advice.
